New hope for leukemia patients Who've run out of options
Disease control
Recruiting now
This early-stage trial is testing a new drug called ELVN-001 for chronic myeloid leukemia (CML). It aims to find the safest dose and see if the drug can reduce leukemia cells in patients whose current treatments have stopped working or caused severe side effects. The study includ…
Phase: PHASE1 • Sponsor: Enliven Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC